NVIDIA Corporation vs. OCEAN BIOMEDICAL INC
NVIDIA Corporation and OCEAN BIOMEDICAL INC are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| NVDA | OCEA | |
|---|---|---|
| Market Cap | $5.45 trillion | — |
| Revenue (TTM) | $253.49 billion | — |
| Net Income (TTM) | $159.61 billion | — |
NVDA and OCEA split the size & scale factors evenly.
Valuation
| NVDA | OCEA | |
|---|---|---|
| P/E Ratio | 34.48 | — |
| Price / Book | 27.90 | — |
| Price / Sales | 21.51 | — |
NVDA and OCEA split the valuation factors evenly.
Profitability
| NVDA | OCEA | |
|---|---|---|
| Net Margin | 62.97% | — |
| Return on Equity | 81.65% | — |
NVDA and OCEA split the profitability factors evenly.
Dividend
| NVDA | OCEA | |
|---|---|---|
| Dividend Yield | 0.44% | — |
| Payout Ratio | 15.31 | — |
NVDA and OCEA split the dividend factors evenly.
Risk & Sentiment
| NVDA | OCEA | |
|---|---|---|
| Short Interest | 0.07% | — |
NVDA and OCEA split the risk & sentiment factors evenly.
Dig deeper: NVDA overview, NVDA financials, OCEA overview, OCEA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.